Reuters logo
BRIEF-KalVista Pharmaceuticals reports Q1 loss per share of $0.51
September 14, 2017 / 11:39 AM / 5 days ago

BRIEF-KalVista Pharmaceuticals reports Q1 loss per share of $0.51

Sept 14 (Reuters) - Kalvista Pharmaceuticals Inc

* KalVista pharmaceuticals reports fiscal first quarter results

* Q1 loss per share $0.51

* Q1 revenue $100,000 versus $1.0 million

* KalVista Pharmaceuticals Inc - ‍Intravitreal Diabetic Macular Edema Candidate KVD001 remains on track for Phase 2 in 2017​

* KalVista Pharmaceuticals Inc - ‍cash and cash equivalents were $26.5 million as of July 31, 2017​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below